Amosulalol
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
(RS)-5-[1-hydroxy-2-[2-(2-methoxyphenoxy)ethylamino]ethyl]-2-methylbenzenesulfonamide | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Legal status |
|
| Routes of administration | Oral |
| Identifiers | |
| CAS Number |
85320-68-9 |
| ATC code | None |
| PubChem | CID 2169 |
| ChemSpider |
2084 |
| UNII |
C69JI1BAU8 |
| KEGG |
D07451 |
| ChEMBL |
CHEMBL152231 |
| Chemical data | |
| Formula | C18H24N2O5S |
| Molar mass | 380.45 g/mol |
| |
| |
| (verify) | |
Amosulalol (INN) is a beta blocker.
References
| ||||||||||||||||||||||
This article is issued from Wikipedia - version of the Tuesday, January 06, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
